Gary Schneider, MSPH, ScD

VP, Real World Evidence, Analytics & Innovation
Lumen Value & Access, Healthcare Consultancy Group
Franklin, United States

Disclosure information not submitted.

Presentation(s):

• Quantifying the Impact of Novel Metastatic Cancer Therapies on Health Disparities in Survival Outcomes Based on Published Aggregate Data

  Sunday, August 27, 2023
  2:30 PM – 2:35 PM ADT